HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Ferguson, G. T. Search for Related Content PubMed PubMed Citation Articles by Ferguson, G. T.

Recommendations for the Management of COPD^*

^* From the Botsford Pulmonary Associates, Farmington Hills, and Wayne State University, Detroit, MI.

Correspondence to: Gary T. Ferguson, MD, FCCP, Botsford Pulmonary Associates, 28080 Grand River Ave, Suite 306N, Farmington Hills, MI 48336

Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American Thoracic Society [ATS], and British Thoracic Society [BTS]) are reviewed and compared. None of the documents uses classic evidence-based documentation, and, in many instances, the recommendations are empiric because of a lack of scientific evidence. Overall, there is strong agreement between the documents. All three guidelines recommend inhaled bronchodilators as first-line therapy. Anticholinergics are noted to be well tolerated, although potential problems with ß₂-agonists are mentioned. The ERS and BTS suggest that inhaled corticosteroids may be of value in patients documented to be steroid responders, whereas the ATS does not recommend their use at all. All three guidelines support the use of oxygen and pulmonary rehabilitation. There are varying levels of disagreement between the guidelines related to the role of spirometry, stratification of disease severity, and the use of theophylline and systemic corticosteroids. Other differences include the role for nebulizers and metered-dose inhalers, secretion clearance methodologies, and the treatment of acute COPD exacerbations and acute respiratory failure. All three guidelines agree that more research is needed to improve our understanding and management of COPD.

Key Words: COPD • evidence-based medicine • management guidelines

This article has been cited by other articles:

				B J Smith, K Dalziel, H J McElroy, R E Ruffin, P A Frith, K A McCaul, and F Cheok Barriers to success for an evidence-based guideline for chronic obstructive pulmonary disease Chronic Respiratory Disease, July 1, 2005; 2(3): 121 - 131. [Abstract] [PDF]

				B J Smith, F Cheok, A R Heard, A J Esterman, A M Southcott, R Antic, P A Frith, K Hender, and R E Ruffin Impact on readmission rates and mortality of a chronic obstructive pulmonary disease inpatient management guideline Chronic Respiratory Disease, January 1, 2004; 1(1): 17 - 28. [Abstract] [PDF]

				J. A Dougherty, B. L Didur, and L. S Aboussouan Long-Acting Inhaled {beta}2-Agonists for Stable COPD Ann. Pharmacother., September 1, 2003; 37(9): 1247 - 1255. [Abstract] [Full Text] [PDF]

				J. Rupp, H. Kothe, A. Mueller, M. Maass, and K. Dalhoff Imbalanced secretion of IL-1{beta} and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients Eur. Respir. J., August 1, 2003; 22(2): 274 - 279. [Abstract] [Full Text] [PDF]

				J. K. Stoller Acute Exacerbations of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 28, 2002; 346(13): 988 - 994. [Full Text] [PDF]

				P. M. A. Calverley The Future for Tiotropium Chest, February 1, 2000; 117(2_suppl): 67S - 69S. [Abstract] [Full Text] [PDF]